Clinical Trials

539 enrolled 20 charts 2 FDA

Leukemia, Leukemia, Myeloid, Acute

NCT02441803 2024-02-22

Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)

11 enrolled 12 charts

Leukemia, Leukemia, Myeloid, Acute

NCT04687098 2023-06-27

Risk-adapted Therapy for Primary Acute Myeloid Leukemia

1,034 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT00002868 2023-06-22

Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

744 enrolled

Leukemia, Leukemia, Myeloid, Chronic-Phase

NCT00840177 2023-05-03

S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia

115 enrolled 12 charts

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute

NCT01154439 2022-10-26

AML1208

11 enrolled

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT00482833 2022-10-12

APL0406

276 enrolled

Leukemia, Leukemia, Promyelocytic, Acute

NCT00003405 2021-10-14

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia

Phase 2 Withdrawn

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT02464657 2021-10-07

Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

44 enrolled 12 charts

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00004878 2020-07-31

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

Phase 2 Withdrawn

Graft vs Host Disease, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

NCT01289457 2020-02-24

Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome

282 enrolled 13 charts

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT02652871 2019-11-15

LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia

36 enrolled

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT01794702 2019-05-30

Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia

65 enrolled 12 charts

Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00458848 2019-02-15

LAL0904

470 enrolled 10 charts

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01025154 2018-10-09

Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction

63 enrolled 6 charts

Leukemia, Leukemia, Myeloid, Acute

NCT00422591 2018-08-23

Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)

175 enrolled 9 charts

Leukemia, Leukemia, Myeloid, Acute

NCT00542971 2018-08-23

Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)

78 enrolled 6 charts

Leukemia, Leukemia, Myeloid, Acute

NCT01692197 2018-07-03

E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes

43 enrolled 11 charts

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT03564704 2018-06-21

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Phase 2/3 Unknown

80 enrolled

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03553238 2018-06-12

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Phase 2/3 Unknown

70 enrolled

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02905994 2018-05-04

Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia

Phase 1 Withdrawn

Leukemia

NCT00469859 2017-03-15

Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

14 enrolled 9 charts

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute

NCT00528398 2017-02-06

Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

111 enrolled 7 charts

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00528450 2016-01-29

Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia

Phase 2 Terminated

1 enrolled 4 charts

Leukemia, Leukemia, Promyelocytic, Acute

NCT01700413 2016-01-28

Efficacy and Toxicity of Increasing Doses of Idarubicin, Cytarabine and G-CSF in Acute Myeloid Leukemia

48 enrolled

Leukemia

NCT00656617 2015-03-09

Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

106 enrolled 6 charts

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00003783 2014-07-28

Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia

36 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003178 2014-07-25

Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia

120 enrolled

Leukemia

NCT00093483 2014-01-13

Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia

61 enrolled

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT00002658 2013-12-19

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

2,000 enrolled

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT00005823 2013-12-18

Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Classical hematologyMyeloidOther hematologic neoplasm

2,000 enrolled

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00025402 2013-12-18

Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia

1,000 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00002701 2013-09-20

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

750 enrolled

Leukemia, Leukemia, Promyelocytic, Acute

NCT00003602 2013-09-20

Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

Classical hematologyMyeloidOther hematologic neoplasm

400 enrolled

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes

NCT00002812 2013-08-26

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

2,078 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00002816 2013-08-22

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

120 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00967057 2013-08-12

Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

470 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00002532 2013-08-07

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia

Phase 2 Unknown

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00002771 2013-08-02

Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

750 enrolled

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00003268 2013-08-02

Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute, Drug-Related Side Effects and Adverse Reactions

NCT00002800 2013-07-03

Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome